International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
University of Chicago · Texas Tech University · +59 more institutions
Abstract
The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. This collaboration was primarily based on input from a clinical advisory committees (CACs) composed of pathologists, hematologists, oncologists, geneticists, and bioinformaticians from around the world. The recent advances in our understanding of the biology of hematologic malignancies, the experience with the use of the 2016 WHO classification in clinical practice, and the results of clinical trials have indicated the need for further revising and updating the classification.…
Citation impact
- FWCI
- 373.74
- Percentile
- 100%
- References
- 266
Authors
68- DADaniel A. ArberCorresponding
University of Chicago
- AOAttilio Orazi
Texas Tech University, Texas Tech University Health Sciences Center
- RPRobert P. Hasserjian
Massachusetts General Hospital
- MJMichael J. Borowitz
Johns Hopkins University, University of Baltimore
- KRKatherine R. Calvo
National Institutes of Health Clinical Center
Topics & keywords
- Hematopathology
- Clinical trial
- Medicine
- Disease
- Myeloid
- Intensive care medicine
- MEDLINE
- Clinical Practice
- Partnerships for the goals